Reduction in pediatric hospitalizations for varicella-related invasive group A streptococcal infections in the varicella vaccine era

Journal of Pediatrics

Volumn 144, Issue 1, 2004, Pages 68-74

  Patel, Roopal A ^a   Binns, Helen J ^a   Shulman, Stanford T ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Division of Infectious Disease   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE;

CLINICAL TRIAL; HOSPITALIZATION; HUMAN; INFORMATION PROCESSING; MEDICAL RECORD; NECROTIZING FASCIITIS; PEDIATRIC HOSPITAL; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; TOXIC SHOCK SYNDROME;

EID: 0345863524     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2003.10.025     Document Type: Article

References (32)

1. Veasy L, Wiedmeier S, Orsmond G, Ruttenberg H, Boucek M, Roth S, et al. Resurgence of acute rheumatic fever in the intermountain area of the United States. N Engl J Med 1987;316:421-7.
2. Hosier D, Craenan J, Teske D, Wheller J. Resurgence of acute rheumatic fever. Am J Dis Child 1987;141:730-3.
3. Wald E, Dashefsky B, Feidt C, Chiponis D, Byers C. Acute rheumatic fever in western Pennsylvania and the tristate area. Pediatrics 1987;80:371-4.
4. Cone L, Woodard D, Schleivert P, Tomory G. Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes. N Engl J Med 1987;317:146-9.
5. Stevens D, Tanner M, Winship J, Swarts R, Ries K, Schlievert P, et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin. N Engl J Med 1989;321:1-7.
6. Demers B, Simor A, Vellend H, Schlievert P, Byrne S, Jamieson F, et al. Severe invasive Group A streptococcal infections in Ontario, Canada, 1987-1991. Clinic Infect Dis 1993;16:792-800.
7. Givner L, Abramson J, Wasilauskas B. Apparent increase in the incidence of invasive group A beta-hemolytic streptococcal disease in children. J Pediatr 1991;118:341-6.
8. Eriksson B, Andersson J, Holm S, Norgren M. Epidemiological and clinical aspects of invasive group A streptococcal infections and the streptococcal toxic shock syndrome. Clin Infect Dis 1998;27:1428-36.
9. Rathore M, Barton L, Kaplan E. Suppurative group A beta-hemolytic streptococcal infections in children. Pediatrics 1992;89:743-6.
10. Centers for Disease Control. Group A beta-hemolytic streptococcal bacteremia: Colorado, 1989. MMWR Morb Mortal Wkly Rep 1990;39:3-11.
11. Givner L. Invasive disease due to group A beta-hemolytic streptococci: continued occurrence in children in North Carolina. South Med J 1998; 19:333-7.
12. Davies H, Matlow A, Scriver S, Schlievert P, Lovgren M, Talbot J, et al. Apparent lower rates of streptococcal toxic shock syndrome and lower mortality in children with invasive Group A streptococcal infections compared with adults. Pediatr Infect Dis J 1994;13:49-56.
13. Laupland K, Davies K, Low D, Schwartz B, Green K, McGeer A. Invasive group A streptococcal disease in children and association with varicella-zoster virus infection. Ontario Group A Streptococcal Study Group. Pediatrics 2000;105:E60. http://www.pediatrics.org/cgi/content/full/ 105/S/e60.
14. Bassetti M, Manno G, Collida A, Ferrando A, Gatti G, Ugolotti E, et al. Erythromycin resistance in Streptococcus pyogenes in Italy. Emerg Infect Dis 2000;6:180-3.
15. Seppala H, Nissinen A, Jarvinen H, Huovinen S, Henriksson T, Herva E, et al. Resistance to erythromycin in group A streptococci. N Engl J Med 1992;326:292-7.
16. Kaplan E. Susceptibility of group A beta-hemolytic streptococcus to thirteen antibiotics: 301 strains from 1994-1997. Pediatr Infect Dis J 1999;18:1069-72.
17. Martin J, Green M, Barbadora K, Wald E. Erythromycin-resistant Group A streptococci in schoolchildren in Pittsburgh. N Engl J Med 2002;346:1200-6.
18. Working Group on Severe Streptococcal Infections. Defining the Group A streptococcal toxic shock syndrome: rationale and consensus definition. JAMA 1993;269:831-3.
19. Aebi C, Ahmed A, Ramilo O. Bacterial complications of varicella in children. Clin Infect Dis 1996;23:698-705.
20. Rhein L, Fleisher G, Harper M. Lack of reduction in hospitalizations and emergency department visits for varicella in the first 2 years post-vaccine licensure. Pediatr Emerg Care 2001;17:101-3.
21. Seward J, Watson B, Peterson C, Mascola L, Pelosi J, Zhang J, et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA 2002;287:606-11.
22. Ratner A. Varicella-related hospitalizations in the vaccine era. Pediatr Infect Dis J 2002;21:927-30.
23. Galil K, Brown C, Lin F, Seward J. Hospitalizations for varicella in the United States, 1998 to 1999. Pediatr Infect Dis J 2002;21:931-4.
24. AAP. Recommendations for the use of live attenuated varicella vaccine. Pediatrics 1995;95:791-6.
25. Centers for Disease Control and Prevention. Advisory Committee on Immunization Practices. Prevention of Varicella: Recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep 1996;45:1-25.
26. Doctor A, Harper M, Fleisher G. Group A beta-hemolytic streptococcal bacteremia: historical overview, changing incidence, and recent association with varicella. Pediatrics 1995;96:428-33.
27. Wheeler M, Roe M, Kaplan E, Schlievert P, Todd J. Outbreak of group A streptococcus septicemia in children: clinical, epidemiologic and microbiologial correlates. JAMA 1991;266:533-7.
28. Kiska D, Thiede B, Caracciolo J, Jordan M, Johnson D, Kaplan E, et al. Invasive group A streptococcal infections in North Carolina: epidemiology, clinical features and genetic and serotype analysis of causative organisms. J Infect Dis 1997;176:992-1000.
29. Davies H, McGeer M, Schwartz B, Green K, Cann D, Simor A, et al. Invasive group A streptococcal infections in Ontario, Canada. N Engl J Med 1996;335:547-54.
30. Tanz R, Shulman S, Kabat W, Kabat K, Cederlund E, Shortridge D, et al. Macrolide resistant group A streptococci: a tale of two seasons (abstract). Pediatric Academic Societies' Meeting, Seattle, May 2003.
31. York M, Gibbs L, Perdreau-Remington F, Brooks G. Characterization of antimicrobial resistance in Streptococcus pyogenes isolates from the San Francisco bay area of northern California. J Clin Microbiol 1999;37: 1727-31.
32. Melo-Cristino J, Fernandes M. Streptococcus pyogenes isolated in Portugal: macrolide resistance phenotypes and correlation with T types: Portuguese Surveillance Group for the Study of Respiratory Pathogens. Microb Drug Resist 1999;5:219-25.